WHO关于 HIV 预防、检测、治疗、服务提供和监测的综合指南

2021-07-16 世界卫生组织 WHO官网

HIV

这些关于艾滋病毒预防、检测、治疗、服务提供和监测的综合指南汇集了不同年龄、人群和环境的现有和新的临床和规划建议,汇集了自 2016 年以来制定的所有世卫组织艾滋病毒相关指南。上一版的艾滋病综合指南。

中文标题:

WHO关于 HIV 预防、检测、治疗、服务提供和监测的综合指南

英文标题:

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

发布机构:

世界卫生组织

发布日期:

2021-07-16

简要介绍:

这些关于艾滋病毒预防、检测、治疗、服务提供和监测的综合指南汇集了不同年龄、人群和环境的现有和新的临床和规划建议,汇集了自 2016 年以来制定的所有世卫组织艾滋病毒相关指南。上一版的艾滋病综合指南。
这些指南将继续按照 HIV 护理的连续性来构建。包括关于新的联合预防方法、HIV 检测、ARV 方案和治疗监测的信息。有一个关于晚期 HIV 疾病的新章节,其中整合了有关重要 HIV 合并症管理的最新指南,包括隐球菌病、组织胞浆菌病和肺结核。关于一般 HIV 护理的一章包含一个关于姑息治疗和疼痛管理的新部分,以及有关治疗几种被忽视的热带疾病(例如内脏利什曼病和布鲁里溃疡)的最新信息。本章还讨论了筛查和治疗 HIV 感染妇女宫颈癌前病变的新建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=WHO关于 HIV 预防、检测、治疗、服务提供和.pdf)] GetToolGuiderByIdResponse(projectId=1, id=154541c00216584b, title=WHO关于 HIV 预防、检测、治疗、服务提供和监测的综合指南, enTitle=Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, guiderFrom=WHO官网, authorId=0, author=, summary=这些关于艾滋病毒预防、检测、治疗、服务提供和监测的综合指南汇集了不同年龄、人群和环境的现有和新的临床和规划建议,汇集了自 2016 年以来制定的所有世卫组织艾滋病毒相关指南。上一版的艾滋病综合指南。, cover=https://img.medsci.cn/2021829/1630245233125_2020535.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Fri Jul 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>这些关于艾滋病毒预防、检测、治疗、服务提供和监测的综合指南汇集了不同年龄、人群和环境的现有和新的临床和规划建议,汇集了自 2016 年以来制定的所有世卫组织艾滋病毒相关指南。上一版的艾滋病综合指南。<br />这些指南将继续按照 HIV 护理的连续性来构建。包括关于新的联合预防方法、HIV 检测、ARV 方案和治疗监测的信息。有一个关于晚期 HIV 疾病的新章节,其中整合了有关重要 HIV 合并症管理的最新指南,包括隐球菌病、组织胞浆菌病和肺结核。关于一般 HIV 护理的一章包含一个关于姑息治疗和疼痛管理的新部分,以及有关治疗几种被忽视的热带疾病(例如内脏利什曼病和布鲁里溃疡)的最新信息。本章还讨论了筛查和治疗 HIV 感染妇女宫颈癌前病变的新建议。</p>, tagList=[TagDto(tagId=451, tagName=HIV)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=451, guiderKeyword=HIV, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5340, appHits=89, showAppHits=0, pcHits=643, showPcHits=5251, likes=0, shares=7, comments=6, approvalStatus=1, publishedTime=Sun Aug 29 22:36:14 CST 2021, publishedTimeString=2021-07-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 21:54:03 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 03:32:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=WHO关于 HIV 预防、检测、治疗、服务提供和.pdf)])
WHO关于 HIV 预防、检测、治疗、服务提供和.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1211963, encodeId=8e9a1211963a0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=364b6401448, createdName=ms3000000877658330, createdTime=Sun Apr 17 18:59:38 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197037, encodeId=af93119e037eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2df6522432, createdName=ms7000000364308239, createdTime=Thu Feb 24 22:49:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180783, encodeId=ff181180e8339, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Wed Jan 05 09:17:19 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014104, encodeId=3243101410491, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Thu Sep 02 22:53:17 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2022-04-17 ms3000000877658330

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1211963, encodeId=8e9a1211963a0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=364b6401448, createdName=ms3000000877658330, createdTime=Sun Apr 17 18:59:38 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197037, encodeId=af93119e037eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2df6522432, createdName=ms7000000364308239, createdTime=Thu Feb 24 22:49:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180783, encodeId=ff181180e8339, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Wed Jan 05 09:17:19 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014104, encodeId=3243101410491, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Thu Sep 02 22:53:17 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2022-02-24 ms7000000364308239

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1211963, encodeId=8e9a1211963a0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=364b6401448, createdName=ms3000000877658330, createdTime=Sun Apr 17 18:59:38 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197037, encodeId=af93119e037eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2df6522432, createdName=ms7000000364308239, createdTime=Thu Feb 24 22:49:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180783, encodeId=ff181180e8339, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Wed Jan 05 09:17:19 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014104, encodeId=3243101410491, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Thu Sep 02 22:53:17 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2022-01-05 红土豆瓣酱

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1211963, encodeId=8e9a1211963a0, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=364b6401448, createdName=ms3000000877658330, createdTime=Sun Apr 17 18:59:38 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197037, encodeId=af93119e037eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2df6522432, createdName=ms7000000364308239, createdTime=Thu Feb 24 22:49:05 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180783, encodeId=ff181180e8339, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Wed Jan 05 09:17:19 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014104, encodeId=3243101410491, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40645466484, createdName=ms8000000682821176, createdTime=Thu Sep 02 22:53:17 CST 2021, time=2021-09-02, status=1, ipAttribution=)]
    2021-09-02 ms8000000682821176

    学习一下

    0

拓展阅读

2010 OARAC 抗逆转录病毒药物使用指南:美国HIV感染孕妇(孕妇健康和减少围产期HIV传播)

艾滋病研究咨询理事会(OARAC,Office of AIDS Research Advisory Council) · 2010-01-01

2010 ACOG临床指南:感染HIV女性的妇科保健

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2010-12-20

WHO:资源匮乏地区HIV携带者的强化结核病例发现和异烟肼预防性治疗指南

世界卫生组织(WHO,The World Health Organization) · 2011-01-01

2011NIH 灾区感染HIV难民治疗指南-供非HIV专业医护人员使用

美国国家卫生研究院(NIH,The National Institutes of Health) · 2011-01-01

2011 OAR 对HIV - 1病毒感染的孕产妇建议使用抗逆转录病毒药物,以防止母婴传播

国家艾滋病研究所(OAR,HIN Office of ADIS Research) · 2011-01-01

2011 OAR 抗逆转录病毒药物的使用指南:感染HIV- 1的成年人和青少年

艾滋病研究咨询理事会(OARAC,Office of AIDS Research Advisory Council) · 2011-01-01